ClinicalTrials.gov record
Active, not recruiting Phase 4 Interventional

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

ClinicalTrials.gov ID: NCT06422689

Public ClinicalTrials.gov record NCT06422689. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 11:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ANCHOR - Assessment of Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

Study identification

NCT ID
NCT06422689
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
AstraZeneca
Industry
Enrollment
1,511 participants

Conditions and interventions

Conditions

Interventions

  • Albuterol and budesonide inhalation aerosol Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 9, 2024
Primary completion
Mar 30, 2027
Completion
Mar 30, 2027
Last update posted
Apr 5, 2026

2024 – 2027

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
Research Site North Hollywood California 91602
Research Site Walnut Creek California 94598
Research Site Louisville Kentucky 40217
Research Site Boston Massachusetts 02111
Research Site Ann Arbor Michigan 48109
Research Site Flint Michigan 48532
Research Site Minneapolis Minnesota 55425
Research Site Asheville North Carolina 28803
Research Site Greenville North Carolina 27834
Research Site DuBois Pennsylvania 15801
Research Site Austin Texas 78738

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06422689, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2026 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06422689 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →